Top Markets
#1 Islamic Coin Islamic Coin +152.79%
#2 Bitway Bitway +44.84%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.79%
#4 Starpower Starpower +35.61%
#5 Pons Pons +31.53%
#6 aelf aelf +28.67%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.64%
#8 SkyAI SkyAI +18.93%
#9 Ocean Protocol Ocean Protocol +18.57%
#10 Marvell Technology (Ondo Tokenized Stock) Marvell Technology (Ondo Tokenized Stock) +14.31%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Modalis Therapeutics Corporation Modalis Therapeutics Corporation

Modalis Therapeutics Corporation

4883
Rank in Stocks #29675
Modalis Therapeutics Corporation focuses on discovering and developing... Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery methods for the central nervous system (CNS), particularly for CNS-related disorders. Founded in 2016, the company was initially known as EdiGENE Corporation before changing its name to Modalis Therapeutics Corporation in August 2019. Its operations are based in Tokyo, Japan.
Share Price
$0.20877985
Market Cap
$20.11M
Change (1 day)
-3.03%
Change (1 year)
-66.13%
Country
JP
Trade Modalis Therapeutics Corporation (4883)

Category

Healthcare
Operating Margin for Modalis Therapeutics Corporation (4883)
Operating Margin as of 2026 TTM: 0.00%
According to Modalis Therapeutics Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Modalis Therapeutics Corporation from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.